Actively Recruiting
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
Led by Hunan Cancer Hospital · Updated on 2024-08-16
500
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the potential usefulness of 18F-FAPI-04 positron emission tomography/computed tomography (PET/CT) and positron emission tomography/magnetic resonance imaging （PET/MR）for the diagnosis of primary and metastatic lesions, detection of recurrence or assessment of pathologic response in various types of cancer.
CONDITIONS
Official Title
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with suspected, newly diagnosed, or previously treated malignant tumors confirmed by MRI, CT, tumor markers, or pathology
- Patients able to provide informed consent and assent following ethics committee guidelines
You will not qualify if you...
- Patients with non-malignant lesions
- Pregnant patients
- Patients unable or unwilling to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hunan Cancer hospital
Changsha, Hunan, China, 410000
Actively Recruiting
Research Team
H
Hui Ye, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here